Named catch-up gap: management identifies where the company visibly lags peers or its own potential, and is already clos
The model's full reasoning — Q1 2024 call → NOWe need to determine if management identifies a specific named dimension on which the company currently underperforms relative to peers, norms, or its own potential, AND describes work already underway to close that specific gap, with management treating closing it as a meaningful source of improvement that doesn't depend on market conditions improving. Look through the transcript. Management discusses various segments. Underperformance: global S&BT segment down 3% due to extended decision-making, e-procurement. That's external. No specific named gap like margins vs peers. They mention investments in GenAI, AI Explorer, but that's growth opportunity not necessarily closing a performance gap. They mention "Our global SPT segment was about 3% when compared to last year as we see economic headwinds continue to result in extended decision-making." That's external. Also "pipeline for these offerings continues to increase, but our conversion rates are lower than planned." That's a gap? They say conversion rates lower than planned, and they are moving to integrate GenAI content. But is that a specific named dimension? Conversion rate in advisory? They say "We believe our move to fully integrate GenAI content we began in April will be responsive to this market ship." That seems like closing a gap? However, the gap is attributed to market conditions? They say "pipeline is increasing, conversion rates lower than planned" due to market shift? They don't specify a benchmark. Also they don't explicitly say they are underperforming relative to peers. They mention "our Oracle segment up 26%", "SAP up 26%", but S&BT down. That's a segment performance gap? They attribute it to external market. Management does not identify a specific measurable gap that they are closing via operational actions with a mechanism. They talk about investments in GenAI, but that's growth, not a gap. They mention "We also continue to invest in growing IP based programs." No. Look for any specific gap: "we are experiencing the significant opportunity that comes from the unlimited transformation of use cases" - that's opportunity. "our conversion rates are lower than planned" - that is a gap but no specific benchmark, and they attribute it to market shift, not to their own deficiency.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| MEG | Montrose Environmental Group, Inc. | Q3 2023 | 2023-11-08 | C+ |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| SWK | Stanley Black & Decker, Inc. | Q1 2023 | 2023-05-04 | D |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| ADNT | Adient plc | Q1 2018 | 2018-01-29 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| STKL | SunOpta Inc. | Q2 2017 | 2017-08-09 | C+ |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| ABM | ABM Industries Incorporated | Q2 2017 | 2017-06-08 | B |
| PPG | PPG Industries, Inc. | Q1 2017 | 2017-04-20 | C |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| SXT | Sensient Technologies Corporation | Q4 2016 | 2017-02-10 | A |
| BC | Brunswick Corporation | Q3 2016 | 2016-10-28 | B+ |
| SON | Sonoco Products Company | Q4 2015 | 2016-02-11 | B |
HOLX · Q4 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly diagnosing Cynosure’s commercial organization as the specific underperforming dimension (salesforce turnover, recruiting, and productivity lagging behind the company’s international business and its own best operations). They then describe concrete, already-executing actions—stopping voluntary turnover, rehiring high performers, instituting 90-day reviews, new compensation, and building “Cynosure 2.0”—as the mechanism to close the gap.
STKL · Q2 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management identifying a specific named gap in the bars segment, where operational issues at a particular facility are causing inefficient production and gross margin losses. They describe a rapid recovery team already executing systematic identification and correction of these issues, treating the gap as closable through their own operational efforts rather than external market improvements — this aligns with the criteria for a meaningful source of improvement.
ADNT · Q1 2018 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly naming the Seat Structures and Mechanisms (SS&M) business as the specific underperforming dimension. They state it is “destroyed shareholder value” when run as currently organized, and that it is “impacting our financial results” with “significant impact.